Geratherm Medical announces preliminary financial figures 2015: Our best business year to date
Strong growth in sales and earnings Sales volume EUR 21.6 million +15.4 % Gross profit margin 65.4 % (2014: 64.4 %…
Strong growth in sales and earnings Sales volume EUR 21.6 million +15.4 % Gross profit margin 65.4 % (2014: 64.4 %…
Geratherm reported in the H1 report 2014 via a share increase of 2% at apoplex a proceeds gain of 560 t €. The valuation…
. - Sales volume EUR 17.4 million +2.2 % - EBITDA EUR 2.627 million -10.9 % - EBITDA margin 15.1 % (2010: 17.4 %) -…
. - Prospective trial at the university hospital Heidelberg considering the application of SRAclinic in stroke units sh…
Apoplex medical technologies, Pirmasens, Geratherm Medical, Geschwenda, 24.08.2010. In a study for detection of paroxys…
/pressemitteilung/pdf/138468/meldung.pdf
/pressemitteilung/pdf/111024/meldung.pdf